CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
PERSONALPROFESSIONAL
SUPPORT
en
Trading
Trading
Ways to trade
CFD trading
Trading platforms
All platforms 
Web platform
Mobile apps
MT4
TradingView
API documentation
Trading info
Margin Calls
How withdrawals work
Fraud prevention
Trading tools
CFD calculator
Demo trading
Markets
Markets
Our markets
Forex
Shares
Indices
Commodities
Cryptocurrencies
Market updates
Market analysis
Pricing
Pricing
Pricing
Charges and fees
Our business model
Markets pricing
Learn
Learn
For trading beginners
Trading Essentials
Risk-management
Market guides
Demo trading
Investmate app
Glossary
For experienced traders
Trading Strategies
Technical analysis
Market analysis
Trading Psychology
IPO Trading
About
About
About us
Leadership team
Why Capital.com?
Our history
Our offices
Contact us
Whitepaper
Is capital.com safe?
Investor Relations
Careers
Get help
Help
Client vulnerability
Work for us
Tech recruitment
Careers
Legal documentation
Terms and policies
Complaints Procedure (CCSV)
Compliance & Legals
Open platformuser
PERSONALPROFESSIONAL
SUPPORT
en
Open platformuser

HomeMarketsSharesEdgewise Therapeutics, Inc.

Trade Edgewise Therapeutics, Inc. - EWTX CFD

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company''s lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.

Latest shares articles

Cocoa price prediction: Third-party target
Cocoa price prediction: Third-party target
Read our cocoa price forecast for 2025 and beyond, with insights from third-party analysts and commodities market experts.
16:12, 14 July 2025
Top 5 biggest short squeezes
Top 5 biggest short squeezes
Explore five iconic short squeeze cases like GameStop & Tesla. Learn how positioning, sentiment & timing drive dramatic market moves.
15:20, 14 July 2025
Nvidia stock forecast: Third-party price target
Nvidia stock forecast: Third-party price target
Discover third-party Nvidia stock forecast predictions for 2025-2030 and beyond, with analyst targets, historical prices, and trading strategies.
15:58, 11 July 2025
Tesla stock forecast: third-party Tesla (TSLA) price target
Tesla stock forecast: third-party Tesla (TSLA) price target
Discover the Tesla (TSLA) stock price forecast, with predictions, price drivers, and Tesla CFDs trading strategies on Capital.com
12:46, 10 July 2025

Read our reviews to find out more about us

Read the feedback from our clients1, whatever their experience level.
2025-07-01
P**** R******

I'm learning the basics of stock investing. This platform is clear and pretty good. I've been using it for over 6 months.

2025-07-01
V***** F******* N***** S****

Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.

2025-06-30
B******

Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.

2025-06-27
G** G******

Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.

2025-06-24
R**************

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-06-22
J*** A.

The app is built to make options and figures easy to understand, great for beginners and intermediate traders. Demo accounts are simple to set up. 100:1 leverage is available.

2025-06-22
D******

Deposits and withdrawals work without issues. Very low spreads. No noticeable fees. Easy to follow.

2025-06-19
d*********

I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️

2025-06-16
f*********

I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.

2025-05-29
C*********

Love the TV integration. Makes traders life smooth and comfortable.

2025-05-20
G****

I’d been paper trading for 2yrs now, went live and this platform is easy for beginners to understand and navigate all important tools to execute all that I learned. Earning now!

2025-04-29
d******

This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one

2025-02-06
N***** B***

User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

4.7
Ratings and Reviews
4.7
Ratings and Reviews
4.6
4.6

Ready to join a leading broker?

Join our community of traders worldwide
1. Create your account2. Make your first deposit3. Start trading